These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 31276904

  • 1. Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions.
    Duman B, Can KC, Ağtaş-Ertan E, Erdoğan S, İlhan RS, Doğan Ö, Kumbasar H, Çamsarı UM.
    Gen Hosp Psychiatry; 2019; 59():67-72. PubMed ID: 31276904
    [Abstract] [Full Text] [Related]

  • 2. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.
    Tseng YL, Huang CR, Lin CH, Lu YT, Lu CH, Chen NC, Chang CC, Chang WN, Chuang YC.
    Medicine (Baltimore); 2014 Sep; 93(11):e66. PubMed ID: 25192484
    [Abstract] [Full Text] [Related]

  • 3. Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients.
    Thomas KL, La AQ, Punia S, Doroudgar S, Perry PJ.
    Ann Clin Psychiatry; 2016 Feb; 28(1):37-42. PubMed ID: 26855984
    [Abstract] [Full Text] [Related]

  • 4. Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy.
    Kwack DW, Kim DW.
    Clin Neurol Neurosurg; 2023 Oct; 233():107962. PubMed ID: 37717359
    [Abstract] [Full Text] [Related]

  • 5. Hyperammonemia following intravenous valproate loading.
    DeWolfe JL, Knowlton RC, Beasley MT, Cofield S, Faught E, Limdi NA.
    Epilepsy Res; 2009 Jul; 85(1):65-71. PubMed ID: 19299111
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CPS1 T1405N polymorphism, HDL cholesterol, homocysteine and renal function are risk factors of VPA induced hyperammonemia among epilepsy patients.
    Chen L, Tian Q, Zhang M, Chen D, Gao X, Yang H, Li H, Li C, Wen J, Li Y, Tian X, Chen P.
    Epilepsy Res; 2019 Aug; 154():139-143. PubMed ID: 31151073
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of valproate-induced hyperammonemia on treatment decision in an adult status epilepticus cohort.
    Habhab SF, Ulvin LB, Taubøll E, Svalheim S, Olsen KB, Horn MA, Heuser K.
    Epilepsy Behav; 2020 Oct; 111():107193. PubMed ID: 32759060
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients.
    Yamamoto Y, Takahashi Y, Suzuki E, Mishima N, Inoue K, Itoh K, Kagawa Y, Inoue Y.
    Epilepsy Res; 2012 Sep; 101(3):202-9. PubMed ID: 22542569
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for hyperammonemia in pediatric patients with epilepsy.
    Yamamoto Y, Takahashi Y, Imai K, Mishima N, Yazawa R, Inoue K, Itoh K, Kagawa Y, Inoue Y.
    Epilepsia; 2013 Jun; 54(6):983-9. PubMed ID: 23409971
    [Abstract] [Full Text] [Related]

  • 13. Differential ammonia decay kinetics indicates more than one concurrent etiological mechanism for symptomatic hyperammonemia caused by valproate overdose.
    Mojumder DK, De Oleo RR.
    Indian J Pharmacol; 2014 Jun; 46(3):345-7. PubMed ID: 24987188
    [Abstract] [Full Text] [Related]

  • 14. Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey.
    Hosseini H, Shafie M, Shakiba A, Ghayyem H, Mayeli M, Hassani M, Aghamollaii V.
    Psychopharmacology (Berl); 2023 Jan; 240(1):149-156. PubMed ID: 36459199
    [Abstract] [Full Text] [Related]

  • 15. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
    Cheng M, Tang X, Wen S, Yue J, Wang H.
    Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.
    Yokoyama S, Yasui-Furukori N, Nakagami T, Miyazaki K, Ishioka M, Tarakita N, Kubo K, Sugawara N, Shimoda K.
    Ther Drug Monit; 2020 Oct; 42(5):766-770. PubMed ID: 32482992
    [Abstract] [Full Text] [Related]

  • 20. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X, Li X, Zhang T, Zhao L.
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):628-634. PubMed ID: 29791065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.